XML 17 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income $ 5,088,000,000 $ 4,095,000,000
Less: Net income attributable to the noncontrolling interest 44,000,000 31,000,000
Net income attributable to Honeywell 5,044,000,000 4,064,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:    
Depreciation 558,000,000 534,000,000
Amortization 304,000,000 298,000,000
Repositioning and other charges 756,000,000 586,000,000
Net payments for repositioning and other charges (519,000,000) (394,000,000)
Pension and other postretirement income (769,000,000) (562,000,000)
Pension and other postretirement benefit payments (67,000,000) (71,000,000)
Stock compensation expense 131,000,000 133,000,000
Deferred income taxes (482,000,000) (77,000,000)
Other (163,000,000) (38,000,000)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:    
Accounts receivable 131,000,000 (408,000,000)
Inventories (459,000,000) (400,000,000)
Other current assets 356,000,000 13,000,000
Accounts payable 466,000,000 404,000,000
Accrued liabilities (412,000,000) (288,000,000)
Net cash provided by operating activities 4,875,000,000 3,794,000,000
Cash flows from investing activities:    
Expenditures for property, plant and equipment (522,000,000) (613,000,000)
Proceeds from disposals of property, plant and equipment 4,000,000 46,000,000
Increase in investments (2,882,000,000) (4,149,000,000)
Decrease in investments 4,634,000,000 2,793,000,000
Cash paid for acquisitions, net of cash acquired (51,000,000) (72,000,000)
Other 250,000,000 (196,000,000)
Net cash provided by (used for) investing activities 1,433,000,000 (2,191,000,000)
Cash flows from financing activities:    
Proceeds from issuance of commercial paper and other short-term borrowings 19,300,000,000 8,808,000,000
Payments of commercial paper and other short-term borrowings (19,153,000,000) (8,608,000,000)
Proceeds from issuance of common stock 242,000,000 463,000,000
Proceeds from issuance of long-term debt 26,000,000 39,000,000
Payments of long-term debt (1,303,000,000) (69,000,000)
Repurchases of common stock (2,308,000,000) (1,335,000,000)
Cash dividends paid (1,669,000,000) (1,554,000,000)
Pre-separation funding 1,604,000,000 0
Other (141,000,000) (131,000,000)
Net cash used for financing activities (3,402,000,000) (2,387,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents (162,000,000) 330,000,000
Net increase (decrease) in cash and cash equivalents 2,744,000,000 (454,000,000)
Cash and cash equivalents at beginning of period 7,059,000,000 7,843,000,000
Cash and cash equivalents at end of period $ 9,803,000,000 $ 7,389,000,000